Atomoxetine EP impurity A(56161-70-7)
- Name: Atomoxetine EP impurity A
- Synonyms:N-methyl-3-phenoxy-3-phenyl-1-propylamine
- Molecular Formula:
- Molecular Weight:241.333
- CAS Registry Number:56161-70-7
- EINECS:
- Melting Point:174 °C
- Water Solubility:
CAS No.56161-70-7 Atomoxetine EP impurity A
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.56161-70-7 Atomoxetine EP impurity A
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 19393-64-7/N-phenyl-N-p-tolyl-hydroxylamine
- 1239968-55-8/C25H27NO5S
- 358720-68-0/N-(2-methyloctyl)cyclohexylamine
- 680591-93-9/C17H14N2O3
- 26567-31-7/C26H24N2O4
- 1649982-55-7/C17H18ClNO3
- 1444430-98-1/4-amino-1-[(2R,3S,4S,5R)-5-azido-3-(tert-butyl-diphenyl-silanyloxy)-4-fluoro-5-hydroxymethyl-tetrahydro-furan-2-yl]-1H-pyrimidin-2-one
- 1416985-66-4/triethyl((4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,4,5,6-tetrahydro-[1,1'-biphenyl]-3-yl)oxy)silane
- 1424382-15-9/C13H14N3O3(1+)*Br(1-)
- 1258458-74-0/2-(5,5-difluoro-hexyl)-oxazole-4-carbonyl azide
- 1238698-54-8/(E)-3-(4-methoxyphenyl)-4-phenylbut-2-en-2-yl 4-methylbenzenesulfonate
- 52881-02-4/3-phenyl-(3ar,8bc)-3a,8b-dihydro-benzo[4,5]thieno[2,3-d]isoxazole 4,4-dioxide
- 854257-38-8/1,2-dibromo-1-isobutoxy-ethane
- 439589-37-4/(R)-2-Benzyl-1-(4-methoxy-benzyl)-4-oxo-azetidine-2-carboxylic acid (1S,2R,4R)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester
- 275816-88-1/3-(6-tert-butyldimethylsilyloxy-2,4-dimethoxyphenyl)-1-(4-methoxyphenyl)-1-ethanol
- 144689-55-4/N-Methyl-2-butyl-1-[(2'-carboxybiphenyl-4-yl)methyl]-4-hydroxymethylimidazole-5-carboxamide
- 1430216-57-1/(R,E)-methyl 4-(2-(3-(5-chloro-2-(1H-tetrazol-1-yl)phenyl)acryloyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoylcarbamate
- 186797-75-1/5-(4-bromo-phenyl)-6-methyl-1,2,3,5-tetrahydro-4,5,7-triaza-cyclopenta[b]naphthalen-8-one
- 1422459-27-5/(S)-2-chloro-5-isopropyl-3-(pyrrolidin-2-yl)pyridine
- 56161-70-7/Atomoxetine EP impurity A
- 1071869-57-2/methyl (2Z)-3-amino-4-(4-chlorophenyl)-6-hydroxy-6-methyl-2-heptenoate
- 1415353-86-4/2-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-N,N-diethyl-8-iodo-3-methylquinolin-5-amine
- 1018471-71-0/3-(isopropylaminomethyl)-N-(4-methyl-3-(3-methyl-1-(6-methylaminopyrimidin-4-yl)-1H-pyrazol-5-ylamino)phenyl)-5-trifluoromethylbenzamide
- 39496-90-7/Methyl 3-(3-chloromethyl-4-methoxybenzoyl)propionate
- 1454681-25-4/(2R,3R,5R,6R,7S,7aR)-6,7-bis(benzyloxy)-5-(benzyloxymethyl)-3-methylhexahydro-1H-pyrrolizin-2-ol
- 1428975-43-2/C9H11BF5N
- 1584133-11-8/C38H54O3Si
- 50866-94-9/17α-trimethylsilylacetylenyl-3-methoxy-1,3,5(10)-estratrien-17β-ol
- 886754-75-2/2,5-difluoro-N'-[(2,3,3-trimethyl-2,3-dihydro-1H-indol-1-yl)acetyl]benzohydrazide
- 1415691-12-1/C20H23NO3S